MedPath

Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)

Phase 2
Completed
Conditions
Immune Thrombocytopenic Purpura
Interventions
Drug: Sym001
Registration Number
NCT00718692
Lead Sponsor
Symphogen A/S
Brief Summary

This trial is designed as a multi-centre, single-dose, exploratory dose-finding, open label trial evaluating the safety and efficacy of Sym001 in 4-9 consecutive cohorts. Subjects will receive a single IV dose of Sym001.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Confirmed presence of thrombocytopenia with platelet count < 30,000/mm3 at the pre-dose visit.
  • History of isolated ITP
  • RhD-positive serology.
  • Previous treatment and response to first line therapy for ITP
Read More
Exclusion Criteria
  • Known clinical picture suggestive of other causes of thrombocytopenia, especially systematic lupus erythematosus,antiphospholipid syndrome, Evans syndrome, immunodeficiency states, lymphoproliferative disorders, liver disease,ingestion of drugs such as quinidine/quinine, heparin and sulfonamides and hereditary thrombocytopenia confirmed by relevant laboratory findings.
  • Suspected infection with HIV, Hepatitis C, H. pylori.
  • Clinical splenomegaly
  • History of abnormal bone marrow examination.
  • Ongoing haemorrhage corresponding to a grade 3 or 4 on the WHO bleeding scale.
  • Underlying haemolytic condition
  • History of splenectomy.
  • Subject is pregnant, breast feeding or intends to become pregnant.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Sym001Patients treated with Sym001
Primary Outcome Measures
NameTimeMethod
Incidence and severity of Adverse Events (AEs), including Serious Adverse Events (SAEs)6 weeks post dosing
Secondary Outcome Measures
NameTimeMethod
Measurements of platelet countsFrom day 1 through week 6

Trial Locations

Locations (59)

Reseach Site 4908

๐Ÿ‡ฉ๐Ÿ‡ช

Halle, Germany

Aysha Hospital Pvt. Ltd., 9109

๐Ÿ‡ฎ๐Ÿ‡ณ

Chennai, India

Apollo Hospital, 9104

๐Ÿ‡ฎ๐Ÿ‡ณ

Hyderabad, India

Univ Nebraska Med Ctr. UNMC, 1005

๐Ÿ‡บ๐Ÿ‡ธ

Omaha, Nebraska, United States

2085 Henry Tecklenburg Drive, 1001

๐Ÿ‡บ๐Ÿ‡ธ

Charleston, South Carolina, United States

Research Site 3203

๐Ÿ‡ง๐Ÿ‡ช

Brugge, Belgium

Research Site 3202

๐Ÿ‡ง๐Ÿ‡ช

Leuven, Belgium

St. John's Medical College Hospital, 9106

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

Research Site 4906, 4907

๐Ÿ‡ฉ๐Ÿ‡ช

Berlin, Germany

Research Site 3201

๐Ÿ‡ง๐Ÿ‡ช

Yvoir, Belgium

Kasturba Medical College Hospital, 9103

๐Ÿ‡ฎ๐Ÿ‡ณ

Udupi, India

Bnai-Zion Medical Center, 9721

๐Ÿ‡ฎ๐Ÿ‡ฑ

Haifa, Israel

Rambam Medical Center, 9723

๐Ÿ‡ฎ๐Ÿ‡ฑ

Haifa, Israel

Western Galilee - Nahariya Hospital, 9722

๐Ÿ‡ฎ๐Ÿ‡ฑ

Nahariya, Israel

Rabin Medical Center, 9724

๐Ÿ‡ฎ๐Ÿ‡ฑ

Petach Tikva, Israel

Tel-Aviv Sourasky Medical Center, 9726

๐Ÿ‡ฎ๐Ÿ‡ฑ

Tel Aviv, Israel

Research site 4801

๐Ÿ‡ต๐Ÿ‡ฑ

Gdansk, Poland

Spitalul Clinic de Urgente Sfantu Spiridon, 4004

๐Ÿ‡ท๐Ÿ‡ด

Iasi, Romania

Regional Clinical Hospital of Nizhny Novgorod, 7003

๐Ÿ‡ท๐Ÿ‡บ

Nizhny Novgorod, Russian Federation

Regional Clinical Hospital na MI Kalinin, 7005

๐Ÿ‡ท๐Ÿ‡บ

Samara, Russian Federation

City Hospital #9 Kyiv Clinical Hospital, 3904

๐Ÿ‡บ๐Ÿ‡ฆ

Kiev, Ukraine

Vinnytsya Regional Clinical Hospital, 3902

๐Ÿ‡บ๐Ÿ‡ฆ

Vinnytsya, Ukraine

The Edith Wolfson Medical Center, 9725

๐Ÿ‡ฎ๐Ÿ‡ฑ

Holon, Israel

"Prof. Dr. Ion Chiricuta" Oncolgy Institute, 4001

๐Ÿ‡ท๐Ÿ‡ด

Cluj-Napoca, Romania

Royal Victoria Infirmery, 4404

๐Ÿ‡ฌ๐Ÿ‡ง

Newcastle Upon Tyne, United Kingdom

Singleton Hospital, 4405

๐Ÿ‡ฌ๐Ÿ‡ง

Swansea, United Kingdom

Research Site 4806

๐Ÿ‡ต๐Ÿ‡ฑ

Krakow, Poland

Research Site 4903

๐Ÿ‡ฉ๐Ÿ‡ช

Duisburg, Germany

Research Site 4901

๐Ÿ‡ฉ๐Ÿ‡ช

Hannover, Germany

Hospital of the University of Pennsylvania, Site 1002

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Research Site 4905

๐Ÿ‡ฉ๐Ÿ‡ช

Essen, Germany

Research Site 4902

๐Ÿ‡ฉ๐Ÿ‡ช

Kรถln, Germany

Research Site 4904

๐Ÿ‡ฉ๐Ÿ‡ช

Regensburg, Germany

Narayana Hrudayalaya Hospitals, 9105

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

MS Ramaiah Memorial Hospital, 9108

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

Columbia Asia Referral Hospital-Yeshwanthpur, 9101

๐Ÿ‡ฎ๐Ÿ‡ณ

Bangalore, India

Research Site 4804

๐Ÿ‡ต๐Ÿ‡ฑ

Wroclaw, Poland

Hammersmith Hosptial, 4402

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Research Site 4805

๐Ÿ‡ต๐Ÿ‡ฑ

Lodz, Poland

Institutul Clinic Fundeni, 4003

๐Ÿ‡ท๐Ÿ‡ด

Bucuresti, Romania

Clinical Center Zemun 3803

๐Ÿ‡ท๐Ÿ‡ธ

Zemun, Serbia

Cherkassy regional oncology center, 3906

๐Ÿ‡บ๐Ÿ‡ฆ

Cherkassy, Ukraine

Hospital Gregorio Maranon, 3405

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

Research Site 4803

๐Ÿ‡ต๐Ÿ‡ฑ

Warszava, Poland

Instytut Hematologii i Transfuzjologii, 4807

๐Ÿ‡ต๐Ÿ‡ฑ

Warszawa, Poland

Brasov Country Hospital, 4002

๐Ÿ‡ท๐Ÿ‡ด

Brasov, Romania

Clinical Center Nis 3802

๐Ÿ‡ท๐Ÿ‡ธ

Nis, Serbia

Research Site 3402

๐Ÿ‡ช๐Ÿ‡ธ

Valencia, Spain

University College, 4401

๐Ÿ‡ฌ๐Ÿ‡ง

London, United Kingdom

Research Site 3401

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

Research Site 4802, 4808

๐Ÿ‡ต๐Ÿ‡ฑ

Warszawa, Poland

Saint Petersburg State Institution Of Healthcare, 7001

๐Ÿ‡ท๐Ÿ‡บ

St. Petersburg, Russian Federation

State Healthcare Institution Tula Regional Clin. Hosp., 7002

๐Ÿ‡ท๐Ÿ‡บ

Tula, Russian Federation

Clinical center Vojvodina 3801

๐Ÿ‡ท๐Ÿ‡ธ

Novi Sad, Serbia

Reseach Site 3403

๐Ÿ‡ช๐Ÿ‡ธ

Barcelona, Spain

Hospital La Princesa, 3404

๐Ÿ‡ช๐Ÿ‡ธ

Madrid, Spain

Gusak Academy of AMS Ukraine, 3905

๐Ÿ‡บ๐Ÿ‡ฆ

Donetsk, Ukraine

St. James's University Hospital, 4403

๐Ÿ‡ฌ๐Ÿ‡ง

Leeds, United Kingdom

Khmelnytskyi Regional Hospital, 3903

๐Ÿ‡บ๐Ÿ‡ฆ

Khmelnytskyi, Ukraine

ยฉ Copyright 2025. All Rights Reserved by MedPath